Bosentan price after medical insurance reimbursement

Bosentan is a dual endothelin receptor antagonist with affinity for ETA and ETB receptors. It can reduce pulmonary and systemic vascular resistance, thereby increasing cardiac output without increasing heart rate, lowering systemic blood pressure, and improving right ventricular function and exercise tolerance. Therefore, it is widely used to treat pulmonary hypertension, especially in patients with symptoms associated with congenital heart disease.

Bosentan dilates blood vessels in the lungs and systemic circulation by inhibiting the action of endothelin, thereby lowering systemic blood pressure and preventing pulmonary vasospasm. This mechanism makes bosentan play an important role in the treatment of pulmonary hypertension, as it can effectively improve patients' exercise tolerance and quality of life.

However, bosentan may also cause some side effects, such as abnormal liver function, anemia, etc., so it should be used with caution and the patient's physiological indicators should be monitored regularly. In addition, this drug is contraindicated in pregnant and breastfeeding women because it may cause harm to the fetus.

In general, bosentan is an effective drug for the treatment of pulmonary arterial hypertension, but when using it, you must strictly follow the doctor's instructions and pay attention to the side effects and contraindications of the drug.

Bosentan tablets are currently on the market in China and have been included in domestic medical insurance reimbursement items. Bosentan on the domestic market is limited to patients with pulmonary arterial hypertension (WHO Group 1) of WHO functional classification II-IV. The post-medical insurance price of 125mg*56 tablets is about 3,000 yuan. It is understood that there are related generic versions of bosentan on the market overseas. The generic version of bosentan listed overseas is produced by India's cipla pharmaceuticals. The price of 125ng*20 tablets is about 400 yuan. Feedback from patients on the generic versions of bosentan launched overseas is also good, and patients can choose the product that suits them according to their own circumstances. If the patient has more questions about bosentan, please consult a medical consultant.